A few weeks ago, the FDA required all its workers to come into the agency’s offices — even those who never worked in those offices. The result was … let’s call it suboptimal. Now, the AP reports, the agency has reversed course, “allowing some of its most prized staffers to work remotely amid worries that recent layoffs and resignations could jeopardize basic functions like approving new medicines.”